A coalition of anti-abortion doctors Tuesday applied to the The US Supreme Court restricts access to a widely used abortion pill in the countryahead of a long-awaited Supreme Court ruling on the matter.

The US Drug Regulatory Agency (FDA) and the Danco lab, which makes the drug mifepristone, “They blatantly violated the law and current regulations (…) and have consistently put politics before women’s health”denounced these associations of gynecologists and paediatricians campaigning against abortion in a text submitted to the Court.

A real legal battle began on April 7 when, after a lawsuit by a coalition of anti-abortion groups, a Texas federal judge, Matthew Kacsmaryk, revoked the FDA-approved marketing authorization for mifepristone. Despite the scientific consensus, he believed it posed risks to women’s health.

An appeals court, appealed by the Joe Biden administration, allowed the abortion pill to remain licensed, but limited the easy access the FDA had granted over the years. His ruling limited the use of the drug to seven weeks of pregnancy, instead of ten, and banned its shipment.

The federal government then urgently appealed to the Supreme Court, which on Friday temporarily suspended access to the abortion pill and suspended the appeals court’s decision to allow more time to review the case. The court ruled that the suspension will run until Wednesday, just before midnight.

“Without a suspension decision, mifepristone will cause further physical complications, emotional trauma and even the death of women,” the anti-abortion doctors argued.

“It will also harm plaintiffs by forcing them to perform abortions that violate their conscience,” they added, asking the Supreme Court to uphold the appeals court decision. In combination with another drug, mifepristone is used for more than half of the abortions in the United States. Since its FDA approval in 2000, more than 5 million women in the country have used the drug.

In about fifteen US states that recently banned abortion, the abortion pill is officially no longer available. The impact of the restrictions, or banning this pill, would therefore mainly affect states where abortion remains legal.